Evidence map›Paper›PMID 25055171›Full record

ArticlePsychological medicine2014

Smoking cessation is associated with lower rates of mood/anxiety and alcohol use disorders.

P A Cavazos-Rehg, N Breslau, D Hatsukami, M J Krauss, E L Spitznagel, R A Grucza, P Salyer, S M Hartz, L J Bierut

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Psychological medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04013724 nacompletednot on this mapstarted 2017, after this paper: background citation

Efficacy of a Group Tobacco Cessation Behavioral Intervention Among Tobacco Users With Concomitant Mental Illness in Kenya: Protocol for a Controlled Clinical Trial

TypeinterventionalSponsorUniversity of NairobiRan2017 to 2019Enrolled100ConditionsMental IllnessArmsGroup tobacco cessation interventions
NCT05181072 nacompletednot on this mapstarted 2022, after this paper: background citation

Assessing the Effectiveness of Virtual Versus In-person Peer-motivation Smoking Cessation Interventions

TypeinterventionalSponsorMorgan State UniversityRan2022 to 2023Enrolled392ConditionsCigarette Smoking, Tobacco UseArmsEnhanced in-person peer-motivation smoking cessation, Virtual peer-motivation smoking cessation
3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 100 citations in OpenAlex.

  1. Smoking cessation for improving mental health.The Cochrane database of systematic reviews · 2021
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Smoking As an Outcome Moderator In the Treatment of Alcohol Use Disorders.Alcohol and alcoholism (Oxford, Oxfordshire) · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Testing the Feasibility and Acceptability of a Religiously-Tailored Text Messaging Intervention to Reduce Smoking Among Somali Muslim Men During Ramadan.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

P A Cavazos-RehgDepartment of Psychiatry,Washington University School of Medicine,St Louis, MO,USA.
N BreslauDepartment of Epidemiology and Biostatistics, College of Human Medicine,Michigan State University,East Lansing, MI,USA.
D HatsukamiDepartment of Psychiatry,University of Minnesota,Minneapolis, MN,USA.
M J KraussDepartment of Psychiatry,Washington University School of Medicine,St Louis, MO,USA.
E L SpitznagelDepartment of Mathematics,Washington University in St Louis,St Louis, MO,USA.
R A GruczaDepartment of Psychiatry,Washington University School of Medicine,St Louis, MO,USA.
P SalyerDepartment of Psychiatry,Washington University School of Medicine,St Louis, MO,USA.
S M HartzDepartment of Psychiatry,Washington University School of Medicine,St Louis, MO,USA.
L J BierutDepartment of Psychiatry,Washington University School of Medicine,St Louis, MO,USA.
Washington University in St. Louis · USMichigan State University · USUniversity of Minnesota · US

Funding

Washington University Institute of Clinical and Translational Sciences (UL1)UL1RR024992 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$45.4M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Washington University Institute of Clinical and Translational SciencesKL2TR000450 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$8.8M
Washington University Institute of Clinical and Translational Sciences (KL2)KL2RR024994 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$8.6M
BUILDING ON BRIDGING THE GAP: ENVIRONMENTAL INFLUENCES ON TEEN SUBSTANCE USER01DA032843 · NIDA · WASHINGTON UNIVERSITY · PI CAVAZOS-REHG, PATRICIA A · 2012 to 2015
$1.5M
POLICY AS ENVIRONMENT : LONG-TERM EFFECTS OF LAWS RESTRICTING YOUTH SUBSTANCE USER01DA031288 · NIDA · WASHINGTON UNIVERSITY · PI GRUCZA, RICHARD A · 2012 to 2015
$1.1M
Novel Use of Gwas for Improved Understanding of Nicotine DependenceK08DA032680 · NIDA · WASHINGTON UNIVERSITY · PI HARTZ, SARAH · 2012 to 2016
$687k
Substance Use Histories and Risky Sexual Behaviors Among Young PersonsK01DA025733 · NIDA · WASHINGTON UNIVERSITY · PI CAVAZOS-REHG, PATRICIA A · 2009 to 2012
$602k
Human Genetics of Addiction: A Study of Common and Specific FactorsK02DA021237 · NIDA · WASHINGTON UNIVERSITY · PI BIERUT, LAURA J. · 2007 to 2011
$567k
NCATS NIH HHS KL2 TR000450NCATS NIH HHS UL1 TR000448NCRR NIH HHS KL2 RR024994NCRR NIH HHS UL1 RR024992NIDA NIH HHS K01 DA025733NIDA NIH HHS K01DA025733NIDA NIH HHS K02 DA021237NIDA NIH HHS K02DA021237NIDA NIH HHS K08 DA032680NIDA NIH HHS R01 DA031288NIDA NIH HHS R01 DA032843
6 · The paper itself

Abstract

backgroundThe psychological outcomes that accompany smoking cessation are not yet conclusive but positive outcomes could help to persuade quitting.

methodWe used data from the longitudinal National Epidemiological Study of Alcohol and Related Conditions. Logistic regression was used to examine associations between cigarette smoking reduction and Wave 2 status of addiction/mental health disorder among daily smokers at Wave 1, stratified by status of the diagnosis of interest at Wave 1. We adjusted for differences in baseline covariates between smokers with different levels of smoking reduction between Wave 1 and Wave 2 using propensity score regression adjustment.

resultsAfter adjusting for propensity scores and other mental health/addiction co-morbidities at Wave 2, among daily smokers who had current or lifetime history diagnosis of the outcome of interest at Wave 1, quitting by Wave 2 predicted a decreased risk of mood/anxiety disorder [adjusted odds ratio (aOR) 0.6, 95% confidence interval (CI) 0.4-0.9] and alcohol disorder (aOR 0.7, 95% CI 0.5-0.99) at Wave 2. Among daily smokers with no lifetime history diagnosis of the outcome of interest at Wave 1, quitting smoking by Wave 2 predicted a decreased risk of drug use disorder at Wave 2 (aOR 0.3, 95% CI 0.1-0.9).

conclusionsThere is no support in our data for the concern that smoking cessation would result in smokers' increased risk of some mental disorders. To the contrary, our data suggest that smoking cessation is associated with risk reduction for mood/anxiety or alcohol use disorder, even among smokers who have had a pre-existing disorder.

Indexed as

AdolescentAdultAgedAlcohol-Related DisordersAnxiety DisordersFemaleHumansLongitudinal StudiesMaleMiddle AgedMood DisordersSmokingSmoking CessationUnited StatesYoung Adult

Identifiers

PMID25055171
PMCPMC4122254
OpenAlexW2158384645

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.